Citation APA
Ruhstaller, T., Giobbie-Hurder, A., Colleoni, M. A., Jensen, M. B., Ejlertsen, B., de Azambuja, E., Neven, P., Láng, I., Jakobsen, E. H., Gladieff, L., Bonnefoi, H., Harvey, V., Spazzapan, S., Tondini, C., Del Mastro, L., Veyret, C., Simoncini, E., Gianni, L., Rochlitz, C., Kralidis, E., Zaman, K., Jassem, J., Piccart-Gebhart, M., Di Leo, A., Gelber, R. R., Coates, A., Goldhirsch, A., Thürlimann, B., & Regan, M. M. (2019). Adjuvant letrozole and tamoxifen alone or sequentially for postmenopausal women with hormone receptor-positive breast cancer: Long-term follow-up of the BiG 1-98 trial. Journal of clinical oncology, 37(2), 105-114. doi:10.1200/JCO.18.00440
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/283900